Jing Chen - 29 Jun 2022 Form 4 Insider Report for Biostage, Inc. (BSTG)

Role
Director
Signature
/s/ Chad Porter, by power of attorney
Issuer symbol
BSTG
Transactions as of
29 Jun 2022
Transactions value $
$0
Form type
4
Filing time
01 Jul 2022, 17:50:39 UTC
Previous filing
10 Nov 2021
Next filing
09 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSTG Stock Option (right to buy) Award $0 +6.24K $0.00 6.24K 29 Jun 2022 Common Stock, par value $0.01 per share 6.24K $4.65 Direct F1
transaction BSTG Stock Option (right to buy) Award $0 +5.02K $0.00 5.02K 29 Jun 2022 Common Stock, par value $0.01 per share 5.02 $4.65 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Stock Option represents the annual equity grant to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on September 29, 2022, December 29, 2022, March 29, 2023 and June 29, 2023.
F2 This Stock Option was granted in lieu of cash compensation otherwise payable to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on the grant date, June 30, 2022, September 30, 2022 and December 31, 2022.

Remarks:

This form has been signed under power of attorney.